Institute for International Research

Know how to achieve

Main menu

My IIR

Login form

Sign Up

Register Today

Online Registration is open.

Customer Service

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200


Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Cell Based Assays in Drug Development for Biopharmaceuticals

October 04 - 06, 2006 | Marriott Fisherman's Wharf, San Francisco, CA

Sponsors

 

    • Brendan Scientific

      Brendan Scientific develops advanced commercial software that provides industry leading data computation and analysis for all immunoassay and bioassay data. Brendan's software features custom weighting, an industry leading 5 parameter logistic curve fitting model, advanced full curve parallelism and relative potency computations, statistical QC analysis, and 21 CFR Part 11 compliance. The methodologies and mathematics used in Brendan's software provide a level of accuracy, reliability and analysis not available with other systems.
       
      http:// www.brendan.com

    • Lancaster Laboratories

      Lancaster Laboratories provides comprehensive analytical services in chemistry and microbiology for the pharmaceutical, biopharmaceutical, medical device, and animal health industries. Founded in 1961, we are one of the nation's largest single-site commercial testing labs. With extensive capacity, technical expertise, and a multiple-shift staff, we can handle projects of any size.
      http://www.lancasterlabs.com

    • MDS Pharma Services

      MDS Pharma Services is a full-service, global Contract Research Organization (CRO). With facilities and resources strategically located around the world, we are able to meet all your clinical research needs through our Early Stage Development and Late Stage Development groups that provide lead optimization, pre-IND research, pharmaceutical and biopharmaceutical development, early clinical research (Phases I-IIa, bioequivalence), bioanalysis, global clinical development (Phases IIb-IV) and central labs.

      http://www.mdsps.com

    • Meso Scale Discovery (MSD)

      Meso Scale Discovery (MSD) develops and markets singleplex and multiplex biomarker assays targeting phosphoproteins, cytokines, and clinical analytes, for use with MSD's SECTOR Imager instruments. Flexible assay formats provide advantages for immunogenicity screening such as excellent drug tolerance, and an expanded set of applications including neutralization, pharmacokinetic, and pharmacodynamics. MSD's platform is based on MULTI-ARRAY technology, a proprietary combination of patterned arrays and electrochemiluminescence detection, enabling large numbers of measurements with exceptional sensitivity, wide dynamic range and convenience.
      http://www.mesoscale.com

Bottom menu

Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved

Powered by Interactive Agency Janmedia Interactive, Inc.